Skip to main content
OpenTrials

Clinical trial condition

Camurati-Engelmann Syndrome

Explore clinical trials studying Camurati-Engelmann Syndrome. Study availability and eligibility vary by location and protocol.

37 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Camurati-Engelmann Syndrome trial results

Recruiting

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

NCT06788990

Conditions
Bone Diseases, Bone Diseases, Developmental, Camurati-Engelmann Syndrome, +17 more
Locations
  • Site # 0137 Birmingham, Alabama, United States
  • Site #0147 Phoenix, Arizona, United States
  • Site #0107 La Jolla, California, United States
  • Site #0106 Los Angeles, California, United States
View all 203 locations
View Trial Details
Recruiting

An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors

NCT06487624

Conditions
Advanced Solid Tumor, Bone Diseases, Bone Diseases, Developmental, +15 more
Locations
  • Prisma Health-Upstate Greenville, South Carolina, United States
  • The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, China
  • Zhejiang Provincial Cancer Hospital Hangzhou, China
  • Xuzhou Central Hospital Xuzhou, China
View Trial Details

Related conditions